Merryn Voysey to Aged, 80 and over
This is a "connection" page, showing publications Merryn Voysey has written about Aged, 80 and over.
Connection Strength
0.006
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021 12 19; 396(10267):1979-1993.
Score: 0.006